Conference Coverage in various Oncology Conferences

Case Study of Oncology Assets
Scope & Objective:

To support the client in congress/ conference coverage of the key/selected assets in Oncology domain presented at AACR 2022, ASCO 2022, and ESMO 2022, by comprehensive pre-conference planning, effective intelligence gathering during the conference, and insightful post-conference reports

Congress Coverage Support:
  • DelveInsight supported the client by creating a focused conference coverage plan in order to gain in-depth assessment of the Oncology assets, their product developmental activities and key milestones
  • In addition to this DelveInsight also provided additional CI support during the conference coverage which included Abstracts/Poster/Session Tracking, CI Tracking of Competitors (Products) through Booth Intelligence, Social Media sentiment analysis, etc.
Congress Plan:
  • The team extracted and classified sessions by priorities
  • Captured detail presentation and understand the business insights
  • KITs and KIQs were aligned with the client’s strategic needs
  • The deliverables enabled the client with the proactive response to competitor activities at AACR 2022, ASCO 2022, and ESMO 2022
  • Senior internal stakeholders were timely informed for the latest business updates

Related Insights

In-Licensing Opportunity
In-Licensing Opportunity

A large client based in USA, involved in drug delivery devices, with effective marketing and commercialization presence across the globe, wanted to in-license potential dMTS based drug delivery asset... [...]

View Case
Out Licensing Opportunity
Out-Licensing Opportunity

A small pharmaceutical client based at Sweden, Europe with capabilities around a neonatal mesenchymal cells involved DelveInsight to identify a licensing partner for their stem cells product, from acr... [...]

View Case
Go-To-Market Strategy
Go-To-Market Strategy

A medium pharmaceutical client based in United States with biosimilar commercial capabilities involved DelveInsight to identify commercial processes and strategies to launch their biosimilar in Europe... [...]

View Case

Fill the form to download the case study

I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.